BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

452 related articles for article (PubMed ID: 30555161)

  • 1. Wiring the depressed brain: optogenetic and chemogenetic circuit interrogation in animal models of depression.
    Muir J; Lopez J; Bagot RC
    Neuropsychopharmacology; 2019 May; 44(6):1013-1026. PubMed ID: 30555161
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Optogenetics to study the circuits of fear- and depression-like behaviors: a critical analysis.
    Belzung C; Turiault M; Griebel G
    Pharmacol Biochem Behav; 2014 Jul; 122():144-57. PubMed ID: 24727401
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Optogenetic and chemogenetic insights into the neurocircuitry of depression-like behaviour: A systematic review.
    Biselli T; Lange SS; Sablottny L; Steffen J; Walther A
    Eur J Neurosci; 2021 Jan; 53(1):9-38. PubMed ID: 31633833
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Selective Manipulation of Neural Circuits.
    Park HG; Carmel JB
    Neurotherapeutics; 2016 Apr; 13(2):311-24. PubMed ID: 26951545
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Progress in understanding mood disorders: optogenetic dissection of neural circuits.
    Lammel S; Tye KM; Warden MR
    Genes Brain Behav; 2014 Jan; 13(1):38-51. PubMed ID: 23682971
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Optogenetic investigation of neural mechanisms for alcohol-use disorder.
    Juarez B; Liu Y; Zhang L; Han MH
    Alcohol; 2019 Feb; 74():29-38. PubMed ID: 30621856
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Translational PET applications for brain circuit mapping with transgenic neuromodulation tools.
    Boehm MA; Bonaventura J; Gomez JL; Solís O; Stein EA; Bradberry CW; Michaelides M
    Pharmacol Biochem Behav; 2021 May; 204():173147. PubMed ID: 33549570
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Optogenetic dissection of neural circuitry: from synaptic causalities to blue prints for novel treatments of behavioral diseases.
    Lüscher C; Pascoli V; Creed M
    Curr Opin Neurobiol; 2015 Dec; 35():95-100. PubMed ID: 26264408
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Light Up the Brain: The Application of Optogenetics in Cell-Type Specific Dissection of Mouse Brain Circuits.
    Lee C; Lavoie A; Liu J; Chen SX; Liu BH
    Front Neural Circuits; 2020; 14():18. PubMed ID: 32390806
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Optogenetic approaches to evaluate striatal function in animal models of Parkinson disease.
    Parker KL; Kim Y; Alberico SL; Emmons EB; Narayanan NS
    Dialogues Clin Neurosci; 2016 Mar; 18(1):99-107. PubMed ID: 27069384
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Of Mice, Men, and Microbial Opsins: How Optogenetics Can Help Hone Mouse Models of Mental Illness.
    Marton TF; Sohal VS
    Biol Psychiatry; 2016 Jan; 79(1):47-52. PubMed ID: 25981174
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Brain circuit dysfunction in specific symptoms of depression.
    Lv QY; Chen MM; Li Y; Yu Y; Liao H
    Eur J Neurosci; 2022 May; 55(9-10):2393-2403. PubMed ID: 33818849
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Potential utility of optogenetics in the study of depression.
    Lobo MK; Nestler EJ; Covington HE
    Biol Psychiatry; 2012 Jun; 71(12):1068-74. PubMed ID: 22322104
    [TBL] [Abstract][Full Text] [Related]  

  • 14. From Synapses to Circuits, Astrocytes Regulate Behavior.
    Lyon KA; Allen NJ
    Front Neural Circuits; 2021; 15():786293. PubMed ID: 35069124
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Optogenetic and chemogenetic manipulation of seizure threshold in mice.
    Kravchenko JA; Goldberg EM; Mattis J
    STAR Protoc; 2023 Mar; 4(1):102019. PubMed ID: 36640370
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Advances in optogenetic and chemogenetic methods to study brain circuits in non-human primates.
    Galvan A; Caiola MJ; Albaugh DL
    J Neural Transm (Vienna); 2018 Mar; 125(3):547-563. PubMed ID: 28238201
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Combined Optogenetic and Chemogenetic Control of Neurons.
    Berglund K; Tung JK; Higashikubo B; Gross RE; Moore CI; Hochgeschwender U
    Methods Mol Biol; 2016; 1408():207-25. PubMed ID: 26965125
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Closed-loop all-optical interrogation of neural circuits in vivo.
    Zhang Z; Russell LE; Packer AM; Gauld OM; Häusser M
    Nat Methods; 2018 Dec; 15(12):1037-1040. PubMed ID: 30420686
    [TBL] [Abstract][Full Text] [Related]  

  • 19. All-Optical Interrogation of Neural Circuits.
    Emiliani V; Cohen AE; Deisseroth K; Häusser M
    J Neurosci; 2015 Oct; 35(41):13917-26. PubMed ID: 26468193
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A Central Amygdala-Ventrolateral Periaqueductal Gray Matter Pathway for Pain in a Mouse Model of Depression-like Behavior.
    Yin W; Mei L; Sun T; Wang Y; Li J; Chen C; Farzinpour Z; Mao Y; Tao W; Li J; Xie W; Zhang Z
    Anesthesiology; 2020 May; 132(5):1175-1196. PubMed ID: 31996550
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 23.